Pharmaron Beijing Co., Ltd — Board/Management Information 2019

Nov 27, 2019

==> picture [117 x 33] intentionally omitted <==

Pharmaron Beijing Co., Ltd. 康龍化成（北京）新藥技術股份有限公司*

(the “Company”)

(A joint stock company incorporated in the People’s Republic of China with limited liability)

(Stock Code: 3759)

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

The members of the board of directors (the “ Board ”) of the Company are set out below:

Executive Directors

Dr. LOU Boliang (chairman of the Board)

Mr. LOU Xiaoqiang

Ms. ZHENG Bei

Non-executive Directors

Mr. CHEN Pingjin

Mr. HU Baifeng

Mr. LI Jiaqing

• Mr. ZHOU Hongbin

Independent non-executive Directors

Mr. DAI Lixin

Ms. LI Lihua

Ms. CHEN Guoqin

Ms. SHEN Rong

• Mr. TSANG Kwan Hung Benson

1

There are four Board committees. The composition of the Board committees is set out in the table below:

below:
CommitteeDirector	AuditCommittee	Remunerationand AppraisalCommittee	NominationCommittee	StrategyCommittee
Dr. LOU Boliang	–	M	M	C
Mr. LOU Xiaoqiang	–	M	–	M
Ms. ZHENG Bei	–	–	M	–
Mr. CHEN Pingjin	–	–	–	M
Mr. HU Baifeng	–	–	–	–
Mr. LI Jiaqing	–	–	–	M
Mr. ZHOU Hongbin	–	–	–	–
Mr. DAI Lixin	–	–	–	M
Ms. LI Lihua	M	M	M	–
Ms. CHEN Guoqin	M	M	C	–
Ms. SHEN Rong	C	C	M	–
Mr. TSANG Kwan HungBenson	–	–	–	–

Notes:

C Chairperson of the relevant Board committees M Member of the relevant Board committees

Hong Kong, November 27, 2019

• For identification purpose only

2